Home
Conditions
Orthomyxoviridae Infections

Clinical trial condition

Orthomyxoviridae Infections

Explore clinical trials studying Orthomyxoviridae Infections. Study availability and eligibility vary by location and protocol.

1,810 public trials 85 recruiting studies

Refine in advanced search Browse all conditions

Orthomyxoviridae Infections trial results

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age

NCT01999842

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Jacksonville, Florida, United States

GSK Investigational Site Stockbridge, Georgia, United States

GSK Investigational Site Boise, Idaho, United States

GSK Investigational Site Erie, Pennsylvania, United States

View Trial Details

Completed

Effects of Lactobacillus Coryniformis CECT5711 on Immune Response to Influenza Vaccination in Adults Over 65.

NCT03167593

Conditions: Immune Response, Infections, Influenza Vaccination, +7 more
Locations: Not specified

View Trial Details

Completed

Prophylactic Efficacy of Relenza Against Influenza A and B

NCT01156701

Conditions: Asthma, Bronchial Diseases, Bronchial Spasm, +29 more
Locations: Not specified

View Trial Details

Completed

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012

NCT03022435

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Not specified

View Trial Details

Completed

Control of Epidemic Influenza Through a School-based Influenza Vaccination Program

NCT00138294

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Scott & White Hospital and Clinic Temple, Texas, United States

Scott & White Hospital and Clinic Waco, Texas, United States

View Trial Details

Completed

Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)

NCT01390792

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults

NCT03154515

Conditions: Acute Respiratory Infection, Common Cold, Infections, +7 more
Locations: State educational institution of higher professional education "Chelyabinsk State Medical Academy of Federal Agency of Health Care and Social Development" Chelyabinsk, Russia

N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology Moscow, Russia

State budgetary health care institution novosibirsk region "city clinical infectious diseases hospital no. 1" Novosibirsk, Russia

North-western State Medical University named after I.I.Mechnikov Saint Petersburg, Russia

View Trial Details

Completed

A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population

NCT00959049

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Chandler, Arizona, United States

Harrisburg, Arkansas, United States

Jonesboro, Arkansas, United States

Little Rock, Arkansas, United States

View all 23 locations

View Trial Details

Completed

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009

NCT01987349

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Safety Study of an Oral Vaccine to Prevent Seasonal Influenza

NCT01688297

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: WCCT Cypress, California, United States

View Trial Details

Orthomyxoviridae Infections

Orthomyxoviridae Infections trial results

Related conditions